全文获取类型
收费全文 | 1709498篇 |
免费 | 121286篇 |
国内免费 | 2555篇 |
专业分类
耳鼻咽喉 | 24120篇 |
儿科学 | 56614篇 |
妇产科学 | 49498篇 |
基础医学 | 256023篇 |
口腔科学 | 48191篇 |
临床医学 | 146612篇 |
内科学 | 328650篇 |
皮肤病学 | 36847篇 |
神经病学 | 130774篇 |
特种医学 | 65739篇 |
外国民族医学 | 429篇 |
外科学 | 261487篇 |
综合类 | 34223篇 |
现状与发展 | 1篇 |
一般理论 | 448篇 |
预防医学 | 127584篇 |
眼科学 | 39877篇 |
药学 | 131192篇 |
1篇 | |
中国医学 | 3270篇 |
肿瘤学 | 91759篇 |
出版年
2018年 | 16139篇 |
2016年 | 13607篇 |
2015年 | 15576篇 |
2014年 | 21518篇 |
2013年 | 32924篇 |
2012年 | 45134篇 |
2011年 | 48502篇 |
2010年 | 28568篇 |
2009年 | 26910篇 |
2008年 | 46838篇 |
2007年 | 50696篇 |
2006年 | 51495篇 |
2005年 | 50237篇 |
2004年 | 48533篇 |
2003年 | 46931篇 |
2002年 | 46298篇 |
2001年 | 77253篇 |
2000年 | 79599篇 |
1999年 | 67172篇 |
1998年 | 18837篇 |
1997年 | 16756篇 |
1996年 | 17203篇 |
1995年 | 16132篇 |
1994年 | 15300篇 |
1993年 | 14286篇 |
1992年 | 53568篇 |
1991年 | 53412篇 |
1990年 | 53079篇 |
1989年 | 51393篇 |
1988年 | 47890篇 |
1987年 | 47019篇 |
1986年 | 44698篇 |
1985年 | 42788篇 |
1984年 | 31811篇 |
1983年 | 27595篇 |
1982年 | 16131篇 |
1981年 | 14491篇 |
1979年 | 30481篇 |
1978年 | 21620篇 |
1977年 | 18553篇 |
1976年 | 17648篇 |
1975年 | 19525篇 |
1974年 | 23093篇 |
1973年 | 22100篇 |
1972年 | 21157篇 |
1971年 | 19822篇 |
1970年 | 18491篇 |
1969年 | 17851篇 |
1968年 | 16732篇 |
1967年 | 14828篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
82.
83.
84.
85.
A Sharma H L Goh N Asokananthan A Bakker G A Stewart H W Mitchell 《The European respiratory journal》2006,27(1):20-28
Mucosal trypsin, a protease-activated receptor (PAR) stimulant, may have an endogenous bronchoprotective role on airway smooth muscle. To test this possibility the effects of lumenal trypsin on airway tone in segments of pig bronchus were tested. Bronchial segments from pigs were mounted in an organ chamber containing Kreb's solution. Contractions were assessed from isovolumetric lumen pressure induced by acetylcholine (ACh) or carbachol added to the adventitia. Trypsin, added to the airway lumen (300 microg x mL(-1)), had no immediate effect on smooth muscle tone but suppressed ACh-induced contractions after 60 min, for at least 3 h. Synthetic activating peptides (AP) for PAR1, PAR2 or PAR3 were without effect, but PAR4 AP caused rapid, weak suppression of contractions. Lumenal thrombin was without effect and did not prevent the effects of trypsin. Effects of trypsin were reduced by N(omega)-nitro-L-arginine methyl ester but not indomethacin. Trypsin, thrombin and PAR4 AP released prostaglandin E2. Adventitially, trypsin, thrombin and PAR4 AP (but not PAR2 AP) relaxed carbachol-toned airways after <3 min. The findings of this study show that trypsin causes delayed and persistent bronchoprotection by interacting with airway cells accessible from the lumen. The signalling mechanism may involve nitric oxide synthase but not prostanoids or protease-activated receptors. 相似文献
86.
AIMS: To examine the effects of agents that alter potassium adenosine triphosphate (KATP) channel activity in beta-cells on cognitive function and counterregulatory hormone responses during acute hypoglycaemia, given the physiological similarities between the pancreatic beta-cell and the hypothalamic glucose-sensitive neurones (GSN) and the widespread distribution of sulphonylurea receptors in neuronal cells throughout the brain. METHODS: Ten healthy males were studied on four occasions and in random order underwent three stepped hypoglycaemic (plasma glucose aims: 3.4, 2.8, 2.4 mmol/l) and one euglycaemic (plasma glucose aim: 5 mmol/l) insulin clamps. Prior to each hypoglycaemic study, volunteers received either 10 mg glibenclamide, or 5 mg/kg diazoxide or placebo orally. Cognitive function, symptom scores and counterregulatory hormone responses were measured at each glycaemic level. RESULTS: There was no statistically significant effect of either drug on the symptoms generated or the counterregulatory hormonal response during hypoglycaemia. However, cognitive function was better preserved during hypoglycaemia in the glibenclamide-treated arm, particularly four-choice reaction time which deteriorated at a plasma glucose 2.5 mmol/l compared with 3.0 mmol/l with diazoxide (P = 0.015) and 2.9 mmol/l with placebo (P = 0.114). CONCLUSIONS: Single doses of pharmacological agents which alter membrane KATP channel activity do not affect the counterregulatory response to hypoglycaemia but may modify cognitive function during cerebral glucopenia. The unexpected effects of glibenclamide on cortical function suggest a novel action of sulphonylureas that warrants further investigation. 相似文献
87.
Background
Hospital episode statistics (HES) is a UK national database for the National Health Service (NHS), now available online. The purpose of this study was to observe trends in ophthalmic operations performed during the period from 1998 to 2004, using this data. 相似文献88.
M B?ttner J Christoffel G Rimoldi W Wuttke 《Experimental and clinical endocrinology & diabetes》2006,114(2):82-90
The lack of estrogen during menopause is associated with various symptoms including osteoporosis, cardiovascular diseases, and menopausal symptoms. For many years, conventional hormone replacement therapy has been successfully used to treat these conditions. However, in light of recent studies that draw attention to potential hazards of conventional HRT, various attempts were undertaken to search for alternatives of classical HRT. Phytoestrogens are supposed to ameliorate various discomforts associated with menopause. Resveratrol (RES) is present in red wine, grapes and peanuts and has been implicated in cardioprotection and prevention of adverse side effects observed after regular HRT. As the pituitary-thyroid axis is a target of estrogen action, we first assessed the effects of E2 administration on thyroid hormone stimulating hormone releasing hormone (TRH)-induced thyroid stimulating hormone (TSH) secretion from pituitary cell cultures in vitro. Our data reveal that E2 treatment augments the TRH-induced TSH secretion. We furthermore designed a long-term study of three months to assess the effects of subcutaneous and oral administration of 17beta-estradiol (E2), as well as the actions of RES on the pituitary-thyroid axis in ovariectomized (OVX) female rats. Our results demonstrate that serum levels of 1.0 and 8.1 microM RES lead to a significant increase in total serum triiodthyronine (T3) levels. OVX induces TSHbeta mRNA in the adenohypohysis and E2 treatment attenuates this effect. Treatment of rats with subcutaneous implants of E2 does not affect the pituitary-thyroid axis, whereas orally applied E2 benzoate (E2B) increases plasma TSH and total thyroxine (T4) in OVX rats. In all animals, we could not detect changes in thyroid morphology as assessed by hematoxylin-eosin (HE) and Perjod-Acid Schiff's (PAS) staining. 相似文献
89.
90.
This review discusses treatment options for men with premature ejaculation (PE), a common sexual dysfunction characterized
by short ejaculatory latency, decreased sexual satisfaction, and distress. For a number of reasons, including embarrassment
and the belief that PE is a normal part of aging, that it has no effective treatment, or that it will resolve itself, few
men with PE seek treatment. Although several treatment options exist (eg, behavioral, cognitive, and sex therapy methods;
desensitizing drugs; off-label use of antidepressants, phosphodiesterase type 5 inhibitors, or à-blockers), the majority of
men with PE are not satisfied with their results. New pharmacologic drugs develped specifically for the treatment of PE are
undergoing evaluation in clinical trials. For example, recent clinical research studies have revealed on-demand administration
of one such drug, dapoxetine, which achieved significant improvements in ejaculatory latency, control over ejaculation, and
satisfaction with sexual intercourse. In addition, partners of men who received dapoxetine likewise reported improved satisfaction
with sexual intercourse. Future studies may reveal that integration of pharmacologic drugs with psychologic and/or behavioral
therapy techniques may be the optimal approach to the management of PE. PE is a treatable condition, and new drugs in development
may provide benefits over those available. 相似文献